Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
PCG Pharmacies AS
AS
Active
Org 920936210
Drotningsvikveien 132, 5179
Godvik
Retail sale of pharmaceutical products
·
NACE 4773
Est. 2018 · 8 years old
13 employees
Monitor
Share
Norway
/
Companies
/
Retail sale of pharmaceutical products
/
PCG Pharmacies AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
32M
24M
16M
8M
0M
2020: 22M
22M
2020
2021: 23M (+5% vs 2020)
23M
+5%
2021
2022: 24M (+4% vs 2021)
24M
+4%
2022
2023: 25M (+4% vs 2022)
25M
+4%
2023
2024: 26M (+4% vs 2023)
26M
+4%
2024
EBITDA
NOK millions
1M
1M
1M
0M
0M
2020: 1M
1M
2020
2021: 1M (0% vs 2020)
1M
0%
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
26 385
24 537
23 809
22 819
21 693
Staff expenses
−4 480
−4 045
−3 943
−3 902
−3 590
EBITDA
994
1 034
1 306
1 178
1 321
Depreciation & amort.
−17
−25
−138
−152
−159
EBIT
977
1 008
1 168
1 026
1 162
Net financials
−20
−10
−1
0
−0
Profit before tax
956
998
1 166
1 026
1 162
Tax
212
271
257
226
256
Net profit
745
727
909
800
906
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
4 997
6 982
5 569
4 759
4 782
Equity
953
459
578
655
245
Long-term debt
0
0
0
0
0
Short-term debt
4 044
6 522
4 992
4 104
4 537
Total debt
4 044
6 522
4 992
4 104
4 537
Financial ratios
5-year trend
EBITDA margin
3,8 %
This company
15,8 %
Market median
This company
Market median
76% below market
2020
2024
Equity ratio
19,1 %
This company
38,2 %
Market median
This company
Market median
50% below market
2020
2024
Return on equity
78,1 %
This company
18,4 %
Market median
This company
Market median
324% above market
2020
2024
Net profit margin
2,8 %
This company
8,1 %
Market median
This company
Market median
65% below market
2020
2024
Asset turnover
5,28×
This company
1,12×
Market median
This company
Market median
371% above market
2020
2024
Debt / equity
4,24×
This company
0,62×
Market median
This company
Market median
584% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on PCG Pharmacies AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
